» Articles » PMID: 28910142

Distinct Phenotypes of Smokers with Fixed Airflow Limitation Identified by Cluster Analysis of Severe Asthma

Abstract

Rationale: Smoking may have multifactorial effects on asthma phenotypes, particularly in severe asthma. Cluster analysis has been applied to explore novel phenotypes, which are not based on any a priori hypotheses.

Objectives: To explore novel severe asthma phenotypes by cluster analysis when including smoking patients with asthma.

Methods: We recruited a total of 127 subjects with severe asthma, including 59 current or ex-smokers, from our university hospital and its 29 affiliated hospitals/pulmonary clinics. Clinical variables obtained during a 2-day hospital stay were used for cluster analysis. After clustering using clinical variables, the sputum levels of 14 molecules were measured to biologically characterize the clinical clusters.

Results: Five clinical clusters, including two characterized by low forced expiratory volume in 1 second/forced vital capacity, were identified. When characteristics of smoking subjects in these two clusters were compared, there were marked differences between the two groups: one had high levels of circulating eosinophils, high immunoglobulin E levels, and a high sinus score, and the other was characterized by low levels of the same parameters. Sputum analysis revealed intriguing differences of cytokine/chemokine pattern in these two groups. The other three clusters were similar to those previously reported: young onset/atopic, nonsmoker/less eosinophilic, and female/obese. Key clinical variables were confirmed to be stable and consistent 3 years later.

Conclusions: This study reveals two distinct phenotypes with potentially different biological pathways contributing to fixed airflow limitation in cigarette smokers with severe asthma.

Citing Articles

Increased adiposity-to-muscle ratio and severity of sinusitis affect quality of life in asthma: Computed tomographic analysis.

Shimizu K, Kimura H, Tanabe N, Tanimura K, Chubachi S, Iijima H J Allergy Clin Immunol Glob. 2024; 3(3):100277.

PMID: 38983113 PMC: 11231708. DOI: 10.1016/j.jacig.2024.100277.


Risk factor analysis and nomogram for predicting poor symptom control in smoking asthmatics.

Ma J, Chen Z, Wu K, Lei J, Zhao L BMC Pulm Med. 2024; 24(1):264.

PMID: 38824531 PMC: 11144325. DOI: 10.1186/s12890-024-03076-9.


EGPA: Eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome) as a special presentation of chronic rhinosinusitis with nasal polyps (CRSwNP).

Hagemann J, Laudien M, Becker S, Cuevas M, Klimek F, Kianfar R Allergol Select. 2024; 8:18-25.

PMID: 38549809 PMC: 10975735. DOI: 10.5414/ALX02475E.


Serum MMP3 and IL1-RA levels may be useful biomarkers for detecting asthma and chronic obstructive pulmonary disease overlap in patients with asthma.

Takada K, Suzukawa M, Tashimo H, Ohshima N, Fukutomi Y, Kobayashi N World Allergy Organ J. 2023; 16(11):100840.

PMID: 38020287 PMC: 10663683. DOI: 10.1016/j.waojou.2023.100840.


Type 1 Error on Type 2 Inflammation: Circular Analysis in Asthma Clustering.

Patchett B, Schulman E Am J Respir Crit Care Med. 2023; 208(6):655-656.

PMID: 37478329 PMC: 10515571. DOI: 10.1164/rccm.202306-0995VP.